This is a $77,030,934 definitive contract awarded by the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR) to T2 Biosystems, Inc., a for-profit manufacturer, to advance the development of rapid, high-throughput, multiplexed detection of biothreat species identification and antibiotic resistance genes using T2MR technology as a countermeasure to diagnose bacterial biothreat pathogens and antibiotic resistance threats. The contract was awarded on September 30, 2019 and has a completion date of September 14, 2023. The original solicitation was a Broad Agency Announcement issued by BARDA to support the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, with a focus on areas including diagnostics. This contract does not have a set-aside designation.
Generated 3/21/24, 8:43 PM